Discover open access scientific publications

Search, annotate, share and cite publications

Publications by William J. Gibson

PIK3CA Amplification Associates With Aggressive Phenotype but Not Markers of AKT-MTOR Signaling in Endometrial Carcinoma

Clinical Cancer Research
Cancer ResearchOncology
2018English

Safety and Efficacy of Rivaroxaban When Added to Aspirin Monotherapy Among Stabilized Post‐Acute Coronary Syndrome Patients: A Pooled Analysis Study of ATLAS ACS‐TIMI 46 and ATLAS ACS 2‐TIMI 51

Journal of the American Heart Association
Cardiovascular MedicineCardiology
2019English

Related publications

High Level of HSF1 Associates With Aggressive Endometrial Carcinoma and Suggests Potential for HSP90 Inhibitors

British Journal of Cancer
Cancer ResearchOncology
2014English

Endometrial Carcinoma May Favor Partial, but Not Complete, Loss of the TGF-β Signaling Pathway

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2019English

PIK3CA Mutations Are Common in Lobular Carcinoma in Situ, but Are Not a Biomarker of Progression

Breast Cancer Research
Cancer ResearchOncology
2017English

Tetrandrine Suppresses Metastatic Phenotype of Prostate Cancer Cells by Regulating Akt/mTOR/MMP-9 Signaling Pathway

Oncology Reports
MedicineCancer ResearchOncology
2016English

Overexpression of CAPN2 Promotes Cell Metastasis and Proliferation via AKT/mTOR Signaling in Renal Cell Carcinoma

Oncotarget
Oncology
2017English

Hydrogen Sulfide Promotes Autophagy of Hepatocellular Carcinoma Cells Through the PI3K/Akt/mTOR Signaling Pathway

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2017English

Targeting the PI3K/AKT/mTOR Signaling Axis in Children With Hematologic Malignancies

Paediatric Drugs
Child HealthPediatricsPerinatologyPharmacology
2012English

Targeting the PI3-Kinase/Akt/mTOR Signaling Pathway

Surgical Oncology Clinics of North America
SurgeryOncology
2013English

DOK7V1 Influences the Malignant Phenotype of Lung Cancer Cells Through PI3K/AKT/mTOR and FAK/paxillin Signaling Pathways

International Journal of Oncology
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy